How long should we follow patients managed for muscle-invasive bladder cancer? Lesson learned from a recent clinical practice
Submitted: June 14, 2022
Accepted: June 17, 2022
Published: September 26, 2022
Accepted: June 17, 2022
Abstract Views: 550
PDF: 281
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.